Dilated cardiomyopathy : from genetics to clinical management /

Saved in:
Bibliographic Details
Uniform title:Dilated cardiomyopathy (Sinagra)
Imprint:Cham (CH) : Springer, 2019.
Description:1 online resource : illustrations
Language:English
Series:Online access: OAPEN DOAB Directory of Open Access Books.
Online access: NCBI NCBI Bookshelf.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12340006
Hidden Bibliographic Details
Other authors / contributors:Sinagra, Gianfranco, editor.
Merlo, Marco, MD, editor.
Pinamonti, Bruno, editor.
ISBN:9783030138639
3030138631
9783030138646
303013864X
9783030138653
3030138658
9783030138660
3030138666
Digital file characteristics:text file PDF
Notes:Includes bibliographical references.
Open access.
Open Access.
Description based on online resource; title from Bookshelf title screen (viewed May 27, 2020).
Summary:Dilated cardiomyopathy (DCM) is a heart muscle disease characterized by left ventricular or biventricular dilation and systolic dysfunction in the absence of either pressure or volume overload or coronary artery disease sufficient enough to explain the dysfunction. DCM is currently a relatively benign disease, with concrete treatment strategies and solid therapeutic regimens. However, clinical management of DCM patients is still one of the most challenging scenarios even for tertiary referral centers. DCM patients are usually young (between their 30s and 50s), still of working age with usually a solid economic and social background. Several pitfalls may be present during diagnostic workup and risk stratification of these patients. First of all, DCM is usually a mostly genetically determined disease. Indeed, the novel techniques of DNA sequencing revealed that genetically determined DCMs are vastly more common than once believed and it is far from being a monogenic disease, with multiple unknown epigenetic interactions. The incomplete penetrance and the epigenetic regulations are responsible for the so-called genotype-positive-phenotype-negative patients. Therefore, the management of information derived from genetic testing, both for probands and for relatives, is still debated and not definite. The continuous effort of researchers to identify the mechanism underlying the disease is fundamental to improving the survival of those patients.
Other form:Print version: Sinagra, Gianfranco. Dilated Cardiomyopathy : From Genetics to Clinical Management. Cham : Springer, ©2019 9783030138639
Standard no.:10.1007/978-3-030-13864-6
10.1007/978-3-030-13